Solesence financials
$0.8200−1.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 |
|---|---|---|---|---|---|
| Revenue | $15.3M | $13.0M | $12.5M | $14.6M | $20.4M |
| Gross profit | $4.7M | $3.3M | $3.4M | $3.4M | $6.4M |
| Gross margin | 31.0% | 25.8% | 27.5% | 23.1% | 31.6% |
| Operating income | $121.0K | -$504.0K | $186.0K | -$781.0K | $2.5M |
| Net income | -$158.0K | -$766.0K | $163.0K | -$1.1M | $3.2M |
| Net margin | −1.0% | −5.9% | 1.3% | −7.7% | 15.9% |
| Diluted EPS | $0.00 | $-0.01 | $0.00 | $-0.02 | $0.04 |
| EBITDA | $444.0K | -$191.0K | $407.0K | -$556.0K | $2.7M |
| Operating cash flow | $191.0K | $1.5M | $1.8M | -$2.5M | -$654.0K |
| Free cash flow | -$278.0K | $989.0K | $1.4M | -$2.9M | -$2.1M |
| Diluted shares | 70.6M | 70.6M | 74.6M | 70.5M | 72.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $1.0M | $573.0K | $1.3M | $429.0K | $4.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $4.8M | $13.5M | $15.3M | $15.8M | $16.6M |
| Total assets | $46.4M | $47.8M | $46.5M | $54.0M | $60.0M |
| Total liabilities | $33.3M | $30.8M | $32.4M | $36.8M | $41.8M |
| Shareholders' equity | $13.2M | $17.0M | $14.1M | $17.2M | $18.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology